SecBot SecBot
424B5 ·Filed Jun 11, 2026

EVGN

Evogene Ltd.
BEARISH
Impact 7/10
Horizonweeks Processed4mo ago SEC0001178913-26-003170
Notable filing: 424B5
Actionable Insight ▼ Bearish

The ATM offering provides a modest cash infusion but does not address the fundamental going concern risk or Nasdaq delisting threat. Monitor for further dilution as shares are sold into weakness. The stock is trading near cash value (~$0.70/share tangible book) with no clear catalyst. Delisting risk by September 28, 2026 is a material overhang.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
EVGN ▼ -13.07% at T+60d
SHORT call ✓ call won +13.07% · α vs SPY +16.33% · entry $0.5839 → $0.5076
Entry = T+0 close
Jun 11, 2026
via day close
T+1d
-0.50%
call +0.50% · α +2.26%
$0.5810
settled 5mo ago
T+5d
-10.07%
call +10.07% · α +10.74%
$0.5251
settled 4mo ago
T+20d
-12.31%
call +12.31% · α +14.09%
$0.5120
settled 4mo ago
T+60d
-13.07%
call +13.07% · α +16.33%
$0.5076
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Evogene Ltd. filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $2,926,500 of ordinary shares through A.G.P./Alliance Global Partners. The company has limited cash resources ($8.5M as of March 31, 2026), is not in compliance with Nasdaq's $1.00 minimum bid price requirement (received a deficiency notice on March 30, 2026), and its auditors identified going concern assessment as a critical audit matter. The offering could dilute existing shareholders by up to ~40% of shares outstanding and provides only modest near-term cash runway extension.

Key Facts

  • ATM offering of up to $2,926,500 of ordinary shares via A.G.P. at 3.0% commission
  • Stock price at filing: $0.597 per share (June 9, 2026); market cap ~$6M
  • Nasdaq deficiency notice received March 30, 2026 for bid price <$1.00; compliance deadline September 28, 2026
  • Auditors identified going concern assessment as a critical audit matter in most recent audit
  • Cash and cash equivalents: $8,511,000 as of March 31, 2026 (actual); pro forma $11,281,000 after full ATM sale
  • Accumulated deficit: $288,426,000 as of March 31, 2026
  • Equity attributable to equity holders was negative $2,545,000 as of March 31, 2026 (actual)
  • Up to 4,902,010 shares could be sold, representing ~40% of pre-offering outstanding shares (12,104,457)
  • Immediate dilution of $0.112 per share for new investors at assumed $0.597 price
  • 5,076,924 warrants outstanding at $1.25 exercise price (deep out-of-the-money)

Financial Impact

Up to $2,926,500 gross proceeds; net proceeds after 3% commission and ~$92,764 expenses would be approximately $2,745,000. Pro forma cash increases from $8.5M to ~$11.3M, extending runway modestly.

dilutioncashequity

Risk Factors

  • Nasdaq delisting if bid price does not reach $1.00 by September 28, 2026
  • Going concern risk; auditors flagged this as critical audit matter
  • Massive dilution: up to 40% of shares outstanding from this ATM alone, plus 5M+ warrants at $1.25 (deep out-of-the-money)
  • Negative equity attributable to holders ($2.5M deficit) indicates balance sheet stress
  • Limited cash runway even after full ATM raise (~$11.3M pro forma cash vs. ongoing burn)

Market Snapshot

Exchange
Nasdaq
Sector
Agricultural Chemicals
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Materials & Mining

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001178913-26-003170
Document: 0001178913-26-003170-index-headers.html0001178913-26-003170
Document: 0001178913-26-003170-index.html0001178913-26-003170
Document: 0001178913-26-003170.txt0001178913-26-003170
16 reports for EVGN
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 7 best @ T+20▲ +27.07%May 20, 2026
Filters
Rows
Reports for EVGN — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
3
NEUTRAL ★ 2/10
$0.3641awaiting T+60—$0.3600 (−1.13%)
Oct 6, 2026
21d ago
SC 13D/A
BULLISH ★ 6/10
$0.4106awaiting T+60—$0.3600 (−12.32%)
Oct 6, 2026
21d ago
6-K
BULLISH ★ 6/10
$0.4106awaiting T+60—$0.3600 (−12.32%)
Sep 30, 2026
27d ago
6-K
BEARISH ★ 6/10
$0.4000awaiting T+60—$0.3600 (+10.00%)
Sep 30, 2026
28d ago
EFFECT
BEARISH ★ 5/10
$0.4000awaiting T+60—$0.3600 (+10.00%)
Sep 4, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$0.5379awaiting T+60—$0.3600 (−33.07%)
Aug 18, 2026
10w ago
6-K
MIXED ★ 6/10
$0.5826awaiting T+60—$0.3600 (−38.21%)
Aug 14, 2026
10w ago
Press Release
NEUTRAL ★ 1/10
$0.6008awaiting T+60—$0.3600 (−40.08%)
Jul 31, 2026
12w ago
6-K
MIXED ★ 6/10
$0.5400 $0.3466▼ −35.81%▼ −37.60%$0.3600 (−33.33%)
Jun 16, 2026
19w ago
6-K
NEUTRAL ★ 3/10
$0.5600 $0.4806▼ −14.18%▼ −15.18%$0.3600 (−35.71%)
Showing 10 of 16

US Market Status

Market Closed — Opens in 9h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026